Evidence map›Paper›PMID 34051738›Full record

ArticleBMC cancer2021

53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.

Fucai Tang, Zechao Lu, Chengwu He, Hanbin Zhang, Weijia Wu, Zhaohui He

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Journal of personalized medicine · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fucai Tang *Department of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, 518033, Guangdong, China.
Zechao Lu *Department of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, 518033, Guangdong, China.
Chengwu HeDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, 518033, Guangdong, China.
Hanbin ZhangThe Second Clinical College of Guangzhou Medical University, Guangzhou, 511436, China.
Weijia WuDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, 518033, Guangdong, China.
Zhaohui HeDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, 518033, Guangdong, China. hechh9@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0003-2289-9603
Sun Yat-sen University · CNSecond Affiliated Hospital of Guangzhou Medical University · CN

Funding

National Key Researchand Development Program of China 2018YFA0902801the research start-up fee for the Eighth Affiliated Hospital, Sun Yat-sen University zdbykyqdf005
6 · The paper itself

Abstract

backgroundThe objectives of this study were to screen out cut-off age value and age-related differentially expressed genes (DEGs) in clear cell renal cell carcinoma (CCRCC) from Surveillance Epidemiology and End Results (SEER) database and The Cancer Genome Atlas (TCGA) database.

methodsWe selected 45,974 CCRCC patients from SEER and 530 RNA-seq data from TCGA database. The age cut-off value was defined using the X-tile program. Propensity score matching (PSM) was used to balance the differences between young and old groups. Hazard ratio (HR) was applied to evaluate prognostic risk of age in different subgroups. Age-related DEGs were identified via RNA-seq data. Survival analysis was used to assess the relationship between DEGs and prognosis.

resultsIn this study, we divided the patients into young (n = 14,276) and old (n = 31,698) subgroups according to cut-off value (age = 53). Age > 53 years was indicated as independent risk factor for overall survival (OS) and cancer specific survival (CSS) of CCRCC before and after PSM. The prognosis of old group was worse than that in young group. Eleven gene were differential expression between the younger and older groups in CCRCC. The expression levels of PLA2G2A and SIX2 were related to prognosis of the elderly.

conclusionFifty-three years old was cut-off value in CCRCC. The prognosis of the elderly was worse than young people. It remind clinicians that more attention and better treatment should be given to CCRCC patients who are over 53 years old. PLA2G2A and SIX2 were age-related differential genes which might play an important role in the poor prognosis of elderly CCRCC patients.

Indexed as

Gene Expression Regulation, NeoplasticAgedAge FactorsAgingBiomarkers, TumorCarcinoma, Renal CellGroup II Phospholipases A2Homeodomain ProteinsHumansKaplan-Meier EstimateKidney NeoplasmsMaleMiddle AgedNerve Tissue ProteinsPrognosisProportional Hazards ModelsBiomarkers, TumorGroup II Phospholipases A2Homeodomain ProteinsNerve Tissue ProteinsPLA2G2A protein, humanSIX2 protein, humanAgeAge-related genesClear cell renal cell carcinomaSurveillance epidemiology and end resultsThe Cancer genome atlas

Identifiers

PMID34051738
PMCPMC8164798
OpenAlexW3155024806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.